FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

103801000001107: Piperazine oestrone sulphate 1.5mg tablet - product


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    11492601000001115 Piperazine oestrone sulphate 1.5mg tablet - product en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    12206501000001118 Piperazine oestrone sulphate 1.5mg tablet - product en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    61179201000001114 Piperazine estrone sulphate 1.5mg tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Piperazine oestrone sulphate 1.5mg tablet - product Is a Product containing precisely estropipate 1.5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
    Piperazine oestrone sulphate 1.5mg tablet - product Availability Available only as a proprietary false Additional relationship Existential restriction modifier
    Piperazine oestrone sulphate 1.5mg tablet - product NHS prescribing status NHS prescribable false Additional relationship Existential restriction modifier
    Piperazine oestrone sulphate 1.5mg tablet - product Legal category Prescription Only Medicine false Additional relationship Existential restriction modifier
    Piperazine oestrone sulphate 1.5mg tablet - product CSM recommendation to report adverse reactions Report only serious adverse reactions to the Committee on Safety of Medicines false Additional relationship Existential restriction modifier
    Piperazine oestrone sulphate 1.5mg tablet - product Product name type Generic name false Additional relationship Existential restriction modifier
    Piperazine oestrone sulphate 1.5mg tablet - product Has active ingredient Estrogen false Inferred relationship Existential restriction modifier
    Piperazine oestrone sulphate 1.5mg tablet - product Has active ingredient Estropipate false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Harmogen 1.5mg tablet Is a False Piperazine oestrone sulphate 1.5mg tablet - product Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start